C Ribot
- Orthopedics and Sports Medicine top 0.1%
- Bone health and osteoporosis research 57
- Bone and Joint Diseases 7
- Oncology top 5%
- Bone health and treatments 19
-
- Menopause: Health Impacts and Treatments 17
-
- Vitamin D Research Studies 9
- Physiology top 5%
-
- Estrogen and related hormone effects 23
-
- Bone Metabolism and Diseases 11
-
- Hip and Femur Fractures 10
C Ribot
87 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 136
- Orthopedics and Sports Medicine 2.6k
- Oncology 964
- Endocrinology, Diabetes and Metabolism 551
- Pathology and Forensic Medicine 564
- Physiology 669
Countries citing papers authored by C Ribot
This map shows the geographic impact of C Ribot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Ribot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Ribot more than expected).
Fields of papers citing papers by C Ribot
This network shows the impact of papers produced by C Ribot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Ribot. The network helps show where C Ribot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Ribot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 0 | |
| 2 | 2005 | 15 | |
| 3 | 2004 | 68 | |
| 4 | 2001 | 25 | |
| 5 | [Recurrent facial nerve paralysis in hereditary neuropathy with liability to pressure palsy]. | 2000 | 5 |
| 6 | 2000 | 30 | |
| 7 | 2000 | 19 | |
| 8 | Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density | 1999 | 5 |
| 9 | Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass | 1999 | 2 |
| 10 | 1999 | 283 | |
| 11 | 1998 | 1 | |
| 12 | Ostéoporose postménopausique : aspects épidémiologiqueset thérapeutiques | 1997 | 1 |
| 13 | 1995 | 43 | |
| 14 | 1995 | 27 | |
| 15 | 1993 | 19 | |
| 16 | 1993 | 109 | |
| 17 | 1990 | 104 | |
| 18 | 1989 | 52 | |
| 19 | 1989 | 1 | |
| 20 | 1987 | 146 |
About C Ribot
C Ribot is a scholar working on Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Genetics, having authored 92 papers that have together received 4.1k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (57 papers), Estrogen and related hormone effects (23 papers), Bone health and treatments (19 papers), Menopause: Health Impacts and Treatments (17 papers), Bone Metabolism and Diseases (11 papers), Hip and Femur Fractures (10 papers), Vitamin D Research Studies (9 papers) and Bone and Joint Diseases (7 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.6k citations), Oncology (964 citations) and Endocrinology, Diabetes and Metabolism (551 citations). C Ribot has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include J. M. Pouillès, Florence Trémollières, J. Louvet, F. Trémollières, J. Dequeker, Güzin Dilşen, C. Gennari, L Miravet, George P. Lyritis and A Rapado. Their work appears in journals such as Osteoporosis International, Bone, Calcified Tissue International, Clinical Endocrinology and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.